Subsequent gene chip screening and experimental analysis indicated that the downregulation of RCAN1-4 could enhance the growth and metastasis of thyroid cancer cells by upregulating NFE2L3 expression (Wang et al., 2017). This evidence concerns the gene NFE2L3 and thyroid cancer.